An international group of experts in diabetes treatment recently published a consensus report on the use of GLP-1 RAs or novel dual GIP/GLP-1 RA tirzepatide as an adjunctive therapy to AID systems in adults with T1D [213]. Here, GLP1R is linked to type 1 diabetes mellitus.